Literature DB >> 18725258

P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin.

Katsuaki Ito1, Hai Thien Nguyen, Yukio Kato, Tomohiko Wakayama, Yoshiyuki Kubo, Shoichi Iseki, Akira Tsuji.   

Abstract

The purpose of the present study was to investigate the role of P-glycoprotein (P-gp) in drug disposition in skin. The distribution of P-gp substrates (rhodamine 123 and itraconazole) to the skin after administration from the epidermal side was lower in P-gp gene knockout (mdr1a/1b(-/-)) mice than that in wild-type mice. Coadministration of propranolol, a P-gp inhibitor, decreased the distribution of itraconazole to the skin in wild-type mice, but not in mdr1a/1b(-/-) mice. These results suggest that P-gp contributes to the influx (from the epidermal side) of its substrates into skin, although P-gp is generally involved in efflux of drugs from various tissues. This finding was supported by the lower vectorial transport of rhodamine 123 from the epidermal to the hypodermal side in mdr1a/1b(-/-) mice in Ussing-type chamber experiments and by the immunohistochemical localization of P-gp throughout the dermal layer. Distribution of itraconazole after intravenous administration, on the other hand, was higher in mdr1a/1b(-/-) mice than that in wild-type mice, suggesting that P-gp transports this drug from the skin to the circulation. The present findings are the first to demonstrate involvement of P-gp in dermal drug disposition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725258     DOI: 10.1016/j.jconrel.2008.08.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

2.  Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.

Authors:  Jacob J Junco; Anna Mancha; Gunjan Malik; Sung-Jen Wei; Dae Joon Kim; Huiyun Liang; Thomas J Slaga
Journal:  Mol Cancer Res       Date:  2013-09-26       Impact factor: 5.852

3.  The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.

Authors:  Luowei Li; Suneet Shukla; Andrew Lee; Susan H Garfield; David J Maloney; Suresh V Ambudkar; Stuart H Yuspa
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

4.  Expression of the ABC transport proteins MDR1 (ABCB1) and BCRP (ABCG2) in bovine rumen.

Authors:  I S Haslam; N L Simmons
Journal:  J Comp Physiol B       Date:  2014-04-20       Impact factor: 2.200

5.  Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin.

Authors:  Luowei Li; Christophe Cataisson; Brittany Flowers; Elise Fraser; Vanesa Sanchez; Chi-Ping Day; Stuart H Yuspa
Journal:  J Invest Dermatol       Date:  2019-01-23       Impact factor: 8.551

Review 6.  Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: Scientific and regulatory perspectives.

Authors:  Laure-Alix Clerbaux; Alicia Paini; Annie Lumen; Hanan Osman-Ponchet; Andrew P Worth; Olivier Fardel
Journal:  Environ Int       Date:  2019-03-08       Impact factor: 9.621

7.  Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers.

Authors:  Dorottya Kocsis; Hichem Kichou; Katalin Döme; Zsófia Varga-Medveczky; Zsolt Révész; Istvan Antal; Franciska Erdő
Journal:  Pharmaceutics       Date:  2022-08-13       Impact factor: 6.525

8.  Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.

Authors:  Anthony L Gaeta; J Brucker Nourse; Karolina Willicott; Luke E McKay; Candice M Keogh; Kylie Peter; Shannon N Russell; Shusei Hamamichi; Laura A Berkowitz; Kim A Caldwell; Guy A Caldwell
Journal:  PLoS Genet       Date:  2022-08-19       Impact factor: 6.020

Review 9.  ABCB1 in dermatology: roles in skin diseases and their treatment.

Authors:  H J Weng; T F Tsai
Journal:  J Mol Med (Berl)       Date:  2021-08-09       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.